Compassionate Same-Day Evaluation & Delivery of XRT for Bony Metastasis in Hospice Patients
Stopped early · Not applicable
Conditions studied: Symptomatic Osseous Bone Lesions From Any Malignancy
In brief
This is a survey study to evaluate the feasibility and effectiveness of an affordable, $400 flat rate, same-day consultation, simulation, and delivery of a single fraction of palliative radiation therapy for patients with symptomatic bony metastatic disease who are currently enrolled in hospice. Treatment planning and delivery of palliative radiotherapy will utilize "standard of care" techniques.
Key facts
- Study ID
- NCT01760941
- Run by
- Virginia Commonwealth University
- People needed
- 1
- Starts
- 2013-03-01
- Expected to finish
- 2015-06-01
- Last updated by the study team
- 2016-02-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Symptomatic osseous bone lesion(s) from any malignancy, whether primary of metastatic, with histological confirmation of malignancy.
- Currently enrolled in hospice and referred for single fraction palliative radiotherapy.
- Performance status (to be evaluated by the radiation oncologist), Karnofsky Performance Scale ≥ 20 or ECOG Performance Scale < 5 .
- Ability to understand and willingness to sign a written informed consent document
You may not qualify if…
- Pregnancy.
- Unable to understand English.
- Unable to complete forms with assistance.
- Concurrent enrollment in a study of pain management involving medications or devices.
Where it is running
- Virginia Commonwealth University/Massey Cancer Center — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.